# SBC Medical Group Holdings Inc (SBC)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/sbc-medical-group-holdings-inc/ JSON: https://steadybase.io/company/sbc-medical-group-holdings-inc.json Checked Nov 10, 2026. Latest filing read: Aug 13, 2026.

## Company

- Legal name: SBC Medical Group Holdings Inc
- Ticker: SBC, SBCWW (Nasdaq, Nasdaq)
- SEC CIK: 0001930313
- Industry: Services-Offices & Clinics of  Doctors of  Medicine (SIC 8011)
- Headquarters: Irvine, CA
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Website: sbc-holdings.com
- LinkedIn: https://www.linkedin.com/company/sbc-medical-group-holdings-inc
- Next earnings date: Nov 13, 2026

## Key facts

- Revenue: $173.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/0001193125-26-127557-index.html
- Operating income: $67.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/0001193125-26-127557-index.html
- Net income: $51.0M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/0001193125-26-127557-index.html
- SG&A: $59.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 27, 2026). Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/0001193125-26-127557-index.html
- Employees: 863 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm
- Shares outstanding: 102,846,943 as of Jul 31, 2026 (10-Q filed Aug 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526347843/0001193125-26-347843-index.html
- Auditor: Malonebailey, LLP, Tokyo, Japan, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm

## Business

,” referred to herein as “Pono,” as a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $173.6M | $67.5M | $51.0M | $59.8M |
| Dec 31, 2024 | $205.4M | $70.3M | $46.6M | $57.7M |
| Dec 31, 2023 | $193.5M | $70.7M | $39.4M | $66.2M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/sbc-medical-group-holdings-inc.json

## Officers and directors

- Yoshiyuki Aikawa, Chairman and CEO. Source: Form 4 filed Apr 29, 2026, https://www.sec.gov/Archives/edgar/data/1930313/000149315226019703/0001493152-26-019703-index.htm
- Yuya Yoshida, Director, Chief Financial Officer and Chief Operating Officer. LinkedIn: https://www.linkedin.com/in/yuya-yoshida-68395a56. Source: 10-K filed Mar 27, 2026, https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm
- Ryoji Murata, Principal Accounting Officer. Source: 10-K filed Mar 27, 2026, https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm
- Mike Sayama, independent director. Source: 8-K filed May 20, 2026, https://www.sec.gov/Archives/edgar/data/1930313/000149315226024609/form8-k.htm
- Fumitoshi Fujiwara, Independent Director. Source: 10-K filed Mar 27, 2026, https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm
- Ken Edahiro, Independent Director. Source: 10-K filed Mar 27, 2026, https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm

## Recent 8-K events

- Aug 13, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/sbc-20260813.htm
- Jul 14, 2026: Item 3.01, Notice of delisting or failure to meet listing standards; Item 3.03, Material modification to rights of security holders; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 5.07, Submission of matters to a vote of security holders; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226033195/form8-k.htm
- May 20, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226024609/form8-k.htm
- May 14, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526222720/sbc-20260514.htm
- Apr 23, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226018603/form8-k.htm
- Mar 27, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226013078/form8-k.htm
- Jan 5, 2026: Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312526001488/sbc-20260105.htm
- Dec 31, 2025: Item 7.01, Regulation FD disclosure; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315225029699/form8-k.htm
- Dec 15, 2025: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312525318331/sbc-20251213.htm
- Nov 14, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1930313/000119312525281439/sbc-20251114.htm

## Insider trades (Form 4)

- Apr 28, 2026: Yoshiyuki Aikawa (Chairman and CEO) sold 465,000 shares, about $1.4M. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226019703/0001493152-26-019703-index.htm
- Apr 21, 2026: Yoshiyuki Aikawa (Chairman and CEO) sold 3,100,000 shares, about $9.4M. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226018813/0001493152-26-018813-index.htm
- Mar 6, 2026: Yoshiyuki Aikawa (Chairman and CEO) sold 4,422,900 shares, about $9.4M. Source: https://www.sec.gov/Archives/edgar/data/1930313/000149315226009608/0001493152-26-009608-index.htm

## Latest filings

- 8-K filed Aug 13, 2026: https://www.sec.gov/Archives/edgar/data/1930313/000119312526347825/sbc-20260813.htm
- 10-K filed Mar 27, 2026: https://www.sec.gov/Archives/edgar/data/1930313/000119312526127557/sbc-20251231.htm
- 10-Q filed Aug 13, 2026: https://www.sec.gov/Archives/edgar/data/1930313/000119312526347843/sbc-20260630.htm
- DEF 14A filed May 28, 2026: https://www.sec.gov/Archives/edgar/data/1930313/000149315226025514/formdef14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/